View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Glide Technologies

Development of a Solid Dose Injection Recombinant Anthrax Vaccine

Free White Paper

Development of a Solid Dose Injection Recombinant Anthrax Vaccine

By Glide Technologies

Development of a Solid Dose Injection Recombinant Anthrax Vaccine

By Glide Technologies
Enter your details to receive the free paper:

Glide Technologies is a UK development company focused on solid dose formulations of therapeutics and vaccines, and non-invasive diagnostics.

Glide’s SDI (solid dose injection) system comprises a re-useable spring powered actuator and a disposable single use cassette, which houses the vaccine formulated in a small solid formulation.

Pressing the loaded Glide SDI against the injection site ‘charges’ a spring in the actuator, which at a preset compression force pushes the vaccine into the subcutaneous layer.

The formulation dissolves, releasing the API or vaccine antigens into the surrounding tissue.

Download to find out more.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology